IP Library › Assignment 026404/0095
Patent Assignment
Reel/Frame 026404/0095

Change of Name

Recorded: 2011-06-07 Received: 2011-06-07 Pages: 8
Assignor
Assignee
VALEANT INTERNATIONAL (BARBADOS) SRL
WELCHES, CHRIST CHURCH, BBX, BB17154, BARBADOS
Covered Properties (37)
Dc Block Rf Coaxial Devices
Application: 13/115,749 →
Bupropion Hydrobromide and Therapeutic Applications
Application: 12/740,223 →
Quick Dissolve Compositions and Tablets Based Thereon
Application: 12/730,339 →
Bupropion Hydrobromide and Therapeutic Applications
Application: 12/672,137 →
Bupropion Hydrobromide and Therapeutic Applications
Application: 12/620,720 →
Bupropion Hydrobromide Polymorphs
Application: 12/536,772 →
Pharmaceutical Compositions
Application: 12/360,673 →
Controlled Release Dosage Forms
Application: 12/328,828 →
Controlled Release Formulations Using Intelligent Polymers
Application: 12/186,853 →
Controlled Release Dosage Forms
Application: 12/169,852 →
Modified-Release Formulations of a Bupropion Salt
Application: 11/993,723 →
Bupropion Hydrobromide and Therapeutic Applications
Application: 11/930,644 →
Modified Release Formulations of at Least One Form of Tramadol
Application: 11/928,908 →
Bupropion Hydrobromide and Therapeutic Applications
Application: 11/834,848 →
Modified Release Formulations of a Bupropion Salt
Application: 11/774,109 →
Multiparticulate Osmotic Delivery System
Application: 11/768,764 →
Modified Release Formulations of a Bupropion Salt
Application: 11/766,213 →
Modified Release Formulations of a Bupropion Salt
Application: 11/766,251 →
Modified Release Formulations of a Bupropion Salt
Application: 11/766,239 →
Modified Release Formulations of a Bupropion Salt
Application: 11/762,840 →
Modified Release Formulations of a Bupropion Salt
Application: 11/762,820 →
Modified Release Formulations of a Bupropion Salt
Application: 11/762,343 →
Modified Release Formulations of a Bupropion Salt
Application: 11/759,413 →
Modified Release Formulations of a Bupropion Salt
Application: 11/755,946 →
Modified Release Formulations of a Bupropion Salt
Application: 11/751,785 →
Modified Release Formulations of a Bupropion Salt
Application: 11/751,768 →
Automobile Body
Application: 29/249,266 →
Modified Release Formulations of a Bupropion Salt
Application: 11/475,252 →
Modified Release Tablet of Bupropion Hydrochloride
Application: 11/451,496 →
Modified Release Compositions of at Least One Form of Tramadol
Application: 10/933,479 →
Chronotherapeutic Diltiazem Formulations and the Administration Thereof
Application: 10/657,752 →
Controlled Release Dosage Forms
Application: 10/370,109 →
Quick Dissolve Compositions and Tablets Based Thereon
Application: 10/176,135 →
Sustained-Release Microgranules Containing Diltiazem as Active Principle
Application: 09/998,911 →
Sustained Release Pharmaceutical Matrix Tablet of Pharmaceutically Acceptable Salts of Diclofenac and Process for Preparation Thereof
Application: 09/945,056 →
Extended Release Metformin Hydrochloride Formulations
Application: 09/845,496 →
Sustained-Release Microgranules Containing Diltiazem as Active Principle
Application: 09/757,628 →